COVID-19 and Its Effects on Chronic Pain Patients

Sponsor
Prince of Songkla University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04715815
Collaborator
(none)
30
15.9

Study Details

Study Description

Brief Summary

Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Many factors can affect pain and its severity.

This study aims to explore how the COVID-19 affects chronic pain patients in terms of pain in general, intensity of pain, desire for pain treatment including follow up visits and pain medication refills as well as sleep.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention (only interview)

Detailed Description

Research question

What are the effects of the COVID-19 on chronic pain patients in terms of pain and pain management?

Conceptual framework

The COVID-19 is a novel emerging infectious disease which has unimaginable and unbelievable large scale distressing effects worldwide.

Up to date, there is no study which aims to evaluate the effects of the COVID-19 on chronic pain patients in terms of pain and pain management. The previous survey in patients focused on the worrisome of them for getting this infection and their confidence in their government to control the COVID-19 situation in the US.

Materials and methods

This study is an in-depth interview. The in-depth interview is the principal method to collect qualitative data by setting up open-ended questions beforehand. Patients who are interviewed, can express their attitudes freely. This method is flexible which words, sentences and questions can be adjusted to suit each interviewee (participant). The process consists of active and intentional listening as well as ask on an in-depth basis. All conversations during the in-depth interview are tape-recorded.

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Effects of COVID-19 on Chronic Pain Patients in Terms of Pain and Pain Management
Anticipated Study Start Date :
Feb 1, 2021
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Jun 1, 2022

Outcome Measures

Primary Outcome Measures

  1. To explain how the COVID-19 affects chronic pain patients in terms of pain and pain management. [January to December 2021]

    An in-depth interview will be conducted to find out how the COVID-19 affects chronic pain patients. The investigators will measure pain intensity and sleep disturbance level by using an 11-point numerical rating scale where 0 means that the patient's pain condition is not affected by the COVID-19 and 10 means that the patient's pain condition is maximally affected. The higher the score is the worse.

Secondary Outcome Measures

  1. To explain how the COVID-19 affects chronic pain patients' psychological status. [January to December 2021]

    An in-depth interview will be performed to find out how the COVID-19 affects the psychological aspect of chronic pain patients. The level of anxiety and stress will be measured using the 11-point verbal numerical rating scale where 0 means that the patient's psychological status is not affected by the COVID-19 and 10 means that the patient's psychological status is maximally affected. The higher the score is the worse.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patients with chronic pain who have been under the health care service of the pain clinic of Songklanagarind hospital.

  • Chronic pain patients are patients with persistent pain for at least 3 months. Pain can be from any etiologies.

  • The expected number of interviwees for this in-depth interview is 30 or until the gathered interview data are saturated.

Exclusion Criteria:
  • Patients who are not willing to participate this study and have time for an in person 'in-depth interview'.

  • Patients who are not influence in Thai language.

  • Patients who are physically or mentally too ill to participate this study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Prince of Songkla University

Investigators

  • Principal Investigator: Sasikaan Nimmaanrat, MD, Faculty of Medicine, Prince of Songkla University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sasikaan Nimmaanrat, Primary Investigator, Head of Pain Clinic, Clinical Associate Professor, Prince of Songkla University
ClinicalTrials.gov Identifier:
NCT04715815
Other Study ID Numbers:
  • REC.63-359-8-1
First Posted:
Jan 20, 2021
Last Update Posted:
Jan 29, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 29, 2021